LDL-Apheresis for FSGS CardioRenal Outcomes

Condition:   Focal Segmental Glomerulosclerosis Intervention:   Other: No intervention Sponsors:   Children's Hospital Medical Center, Cincinnati;   Kaneka Pharma America LLC Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials